Connecture Announces The Sale Of Its Commercial U65 Business Unit to Benefitfocus
BROOKFIELD, Wis. — February 26, 2019 – Connecture, Inc. announces the sales of its Commercial U65 business unit to Benefitfocus
With the sale of the U65 business, Connecture ensures a dedicated focus on its Medicare business, which includes the PlanCompare, Brokerlink, and DrugCompare platforms. With this now exclusively SaaS suite of solutions, Connecture is positioned to more efficiently target investments that will enable its customers’ evolution and growth in the Medicare and drug price comparison spaces.
“The Commercial business unit has done a great job delivering, innovating and launching tools and platforms that fit nicely alongside the Benefitfocus portfolio,” said Kraig McEwen, CEO of Connecture.
“This is a signal of both our renewed laser focus on our Medicare business and the vibrancy of the Commercial business which is now part of Benefitfocus. We look forward to partnering during this period of transition and continuing to support market success for our customers.”